Unknown PHASE3 INTERVENTIONAL 2-arm NCT02958033

Shandong Cancer Hospital Affiliated to Shandong University

Sponsor: Shandong Cancer Hospital and Institute

Conditions Breast Conserving Surgery Early-stage Breast Cancer

Interventions Whole Breast irradiation Plus simultaneous tumor bed Boost

Updated 6 times since 2017 Last updated: Nov 4, 2016 Started: Nov 30, 2016 Primary completion: Nov 30, 2019 Completion: Nov 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Breast Conserving Surgery and Early-stage Breast Cancer and is currently ongoing. Shandong Cancer Hospital and Institute leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Dec 2024 — Present [monthly]

Unknown PHASE3

Status: Recruiting → Unknown
Sep 2024 — Dec 2024 [monthly]

Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE3
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE3
Jun 2018 — Jan 2021 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shandong Cancer Hospital and Institute

Data source: Shandong Cancer Hospital and Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jinan, China